Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Accumulated Depreciation & Amortization: 2012-2017

Historic Accumulated Depreciation & Amortization for Tenax Therapeutics (TENX) over the last 3 years, with Sep 2017 value amounting to $573,025.

  • Tenax Therapeutics' Accumulated Depreciation & Amortization fell 5.19% to $573,025 in Q3 2017 from the same period last year, while for Sep 2017 it was $2.3 million, marking a year-over-year decrease of 22.20%. This contributed to the annual value of $567,625 for FY2016, which is N/A change from last year.
  • According to the latest figures from Q3 2017, Tenax Therapeutics' Accumulated Depreciation & Amortization is $573,025, which was down 0.36% from $575,081 recorded in Q2 2017.
  • Tenax Therapeutics' 5-year Accumulated Depreciation & Amortization high stood at $999,003 for Q1 2013, and its period low was $567,625 during Q4 2016.
  • For the 3-year period, Tenax Therapeutics' Accumulated Depreciation & Amortization averaged around $628,386, with its median value being $575,081 (2017).
  • Data for Tenax Therapeutics' Accumulated Depreciation & Amortization shows a maximum YoY fell of 24.18% (in 2016) over the last 5 years.
  • Quarterly analysis of 4 years shows Tenax Therapeutics' Accumulated Depreciation & Amortization stood at $828,752 in 2013, then reached $748,604 in 2015, then declined by 24.18% to $567,625 in 2016, then dropped by 5.19% to $573,025 in 2017.
  • Its Accumulated Depreciation & Amortization was $573,025 in Q3 2017, compared to $575,081 in Q2 2017 and $571,657 in Q1 2017.